Clinical Research |
A controlled three-month clinical test of NAAVUDI on thirty diabetic subjects yielded very positive outcomes in almost all cases. The test was supervised by a senior diabetes specialist, Dr. K.N. Devendra at Sir Sunder Lal Hospital, affiliated with the Institute of Medical Sciences under the auspices of Benaras Hindu University, Varanasi, India. Parameters tested were: |
- Reduction in fasting and post-prandial blood-glucose-sugar levels
- Desirable changes in body-mass index (BMI)
- Changes in blood hemoglobin level
- Changes in serum cholesterol levels
- Changes in levels of blood urea and of serum creatinine
- The presence or absence of symptoms (subjective opinion)
|
Many summarized positive outcomes were evaluated as statistically significant at the 0.001 level. Numerical results are presented below.
Objective measurements of diabetic patient health parameters showed good improvement: |
|
| Item |
Parameter
(Mean Value) |
Units |
Before Treatment |
3 Months Later |
Probability |
| 1 |
Body Mass
Index (BMI) |
-- |
25.96 |
24.88 |
< 0.01 |
| 2 |
Fasting
Blood Sugar |
mg% |
170.37 |
109.8 |
< 0.001 |
| 3 |
Post-Prandial
Blood Sugar |
mg% |
243.93 |
164.77 |
< 0.001 |
| 4 |
Hemiglobin |
mg% |
11.58 |
13.27 |
< 0.001 |
| 5 |
Serum
Cholesterol |
mg% |
229.90 |
194.03 |
< 0.001 |
| 6 |
Blood Urea |
mg% |
38.23 |
33.23 |
< 0.001 |
| 7 |
Serum
Creatinine |
mg% |
1.57 |
1.32 |
< 0.001 |
|
|
'Probability' here refers to statistical significance -- the probability that the desirable result would have occurred purely by chance. 'Post-prandial' generally means two hours after eating.
The majority of the patients had a body mass at the beginning of the study characterized as overweight. At the three-month check point, they had made good progress towards a healthier body mass.
Mean blood-glucose-sugar readings, both fasting and post-prandial, fell dramatically. Mean hemoglobin levels rose significantly, marking improvement in general health. Serum cholesterol levels fell, considerably reducing the risk of diabetes-related ischemic heart disease. Mean blood urea levels and mean serum creatinine levels moved in a healthy direction downwards, indicating that NAAVUDI improved patients' kidney function while helping to protect their kidneys.
More subjective measurements of patient health likewise improved: |
|
| Item |
Sympt |
# of Cases
Before Treatment |
# of Cases
3 Months Later |
# of Cases
Improved |
Percentage
of Cases
Improved |
| 1 |
Polyuria
(Excessive Need
to Urinate) |
24 |
0 |
24 |
100 |
| 2 |
Polydipsia
(Excessive Thirst) |
29 |
0 |
29 |
100 |
| 3 |
Increased Appetite |
14 |
0 |
14 |
100 |
| 4 |
Weakness |
30 |
3 |
27 |
90 |
| 5 |
Fatigue |
30 |
3 |
27 |
90 |
| 6 |
Feeling of
Cold in Hands
and Feet |
4 |
0 |
4 |
100 |
| 7 |
Burning
Sensation |
18 |
2 |
16 |
89 |
| 8 |
Numbness |
9 |
0 |
9 |
100 |
| 9 |
Paresthesia |
5 |
1 |
4 |
80 |
| 10 |
Muscular
Pain |
30 |
0 |
30 |
100 |
|
|
Paresthesia is the medical name for sensations of tingling, pricking , or numbness in the skin with no long-term effects.
The group of patients all experienced substantial quality-of-life improvements as noted in the table, and also reported greatly improved subjective feelings of well-being. |
 |